Skip to main content
. 2015 Jan 31;21(2):174–185. doi: 10.1007/s13365-015-0317-3

Table 1.

Patient sample demographics

Patient ID Age Sex Race HIV status Neurocog diagnosis Plasma VL CSF VL CD4 ARV
Case 1 47 F Black Neg Normal NA NA NA NA
Case 2 44 F White Neg Normal NA NA NA NA
Case 3 51 M White/Hispanic Neg Normal NA NA NA NA
Case 4 49 M White Neg Normal NA NA NA NA
Case 5 46 M White Neg Normal NA NA NA NA
Case 6 39 M Hispanic Pos ANI 570 <50 79 Yes
Case 7 43 M White Pos ANI 249 19 7 Yes
Case 8 39 M White Pos MND 72,125 70 1 Yes
Case 9 33 M Hispanic Pos MND 400 NT 11 Yes
Case 10 35 M White Pos MND/HAD (HIVE) 2827 78 211 Yes
Case 11 37 M White Pos MND 178 5968 85 Yes
Case 12 31 M White Pos MND 483,758 148 10 Yes
Case 13 57 M Asian Pos HAD 40,133 2747 299 Yes
Case 14 30 F Hispanic Neg Normal NA NA NA NA
Case 15 48 F Hispanic Neg Normal NA NA NA NA
Case 16 50 M Hispanic Neg Normal NA NA NA NA
Case 17 56 F White Neg NA NA NA NA NA
Case 18 57 M Black Pos MND 63,953 NT 194 Yes
Case 19 34 M White Pos ANI >750,000 NT 9 Yes
Case 20 46 M White Pos ANI <50 <50 233 Yes
Case 21 45 M Hispanic Pos MND/HAD 628 376 28 Yes
Case 22 31 F Hispanic Pos MND/HAD 744,349 NT 4 Yes
Case 23 55 F Black Pos ANI 37,060 NT 114 Yes
Case 24 56 F White Neg Normal NA NA NA NA
Case 25 38 M White Neg ALS NA NA NA NA
Case 26 53 F White Neg ALS NA NA NA NA
Case 27 50 M White Neg ALS NA NA NA NA
Case 28 54 M White Neg ALS NA NA NA NA
Case 29 57 F Hispanic Neg ALS NA NA NA NA

Data are from last clinic visit. Age at death

NA not applicable, NT not available, HIV Neg seronegative, HIV Pos seropositive, VL viral load, ARV antiretroviral use, ANI asymptomatic neurocognitive impairment, MND minor neurocognitive disorder, HAD HIV-associated dementia, ALS amyotrophic lateral sclerosis